NeuroRelief Ketamine & Infusion Therapy

NeuroRelief Ketamine & Infusion Therapy is a United States based startup operating in the Health Care industry since 2019. The company's mission is to provide individualized treatment for mood, PTSD, anxiety, migraine, chronic pain, and substance abuse disorders. Led by a Board-Certified Anesthesiologist team, NeuroRelief offers a concierge-like service to ensure the best experience for each patient. Their approach has garnered positive feedback, with clients reporting immediate and lasting relief for their mood and physical well-being. The startup focuses on offering personalized care and attention, aiming to revolutionize the treatment of the mentioned conditions. Although no specific investment information is available at the moment, NeuroRelief's commitment to providing tailored treatment and exceptional patient experience positions them as a prospective venture for investment in the health care sector. With the increasing focus on mental health and personalized medicine, NeuroRelief's innovative approach presents an enticing investment opportunity for venture capitalists seeking to support disruptive solutions in the healthcare space.